H2.0-Like Homeobox (HLX) (C-Term) Peptide
HLX
Reactivity: Human
Host: Synthetic
BP, WB
Quick Overview for H2.0-Like Homeobox (HLX) (C-Term) Peptide (ABIN5513065)
Target
HLX
(H2.0-Like Homeobox (HLX))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- RHSKEAQAQK DKDKEAGEKP SGGAPAADGE QDERSPSRSE GEAESESSDS
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-HLX Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HLX (H2.0-Like Homeobox (HLX))
-
Background
-
HLX is a transcription factor required for TBX21/T-bet-dependent maturation of Th1 cells as well as maintenance of Th1-specific gene expression. It involved in embryogenesis and hematopoiesis.
Alias Symbols: HLX,HLX1,
Protein Size: 488 -
Gene ID
- 3142
-
NCBI Accession
- NP_068777
-
UniProt
- Q14774
Target
-
You are here:
